| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 4 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 2 | 0 | 5 |
| AR protein | 8 | 0 | 0 | 8 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| estrogen nuclear receptor alpha | 11 | 0 | 0 | 11 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
| ATP-binding cassette sub-family C member 3 | 0 | 11 | 0 | 11 |
| Multidrug resistance-associated protein 4 | 0 | 11 | 0 | 11 |
| Bile salt export pump | 0 | 3 | 0 | 3 |
| Bile salt export pump | 0 | 13 | 0 | 13 |
| Beta-lactamase SHV-1 | 0 | 1 | 0 | 3 |
| Beta-lactamase SHV-1 | 0 | 3 | 0 | 8 |
| Cytochrome P450 2C9 | 0 | 3 | 0 | 5 |
| Beta-lactamase | 0 | 2 | 0 | 7 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 3 |
| Solute carrier family 15 member 1 | 0 | 3 | 0 | 3 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 2 | 0 | 3 |
| B2 metallo-beta-lactamase | 0 | 0 | 0 | 4 |
| Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Canalicular multispecific organic anion transporter 1 | 0 | 11 | 0 | 11 |
| Beta-lactamase | 0 | 1 | 0 | 4 |
| Beta-lactamase | 0 | 2 | 0 | 4 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 4 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 1 | 4 |
| Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 3 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 3 |
| Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 2 | 0 | 4 |
| Beta-lactamase | 0 | 1 | 0 | 4 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Solute carrier family 22 member 5 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 2 | 0 | 5 |
| Beta-lactamase | 0 | 3 | 0 | 8 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Beta-lactamase TEM | 0 | 5 | 0 | 9 |
| Beta-lactamase | 0 | 1 | 0 | 4 |
| Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 2 | 0 | 4 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 3 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 4 |
| Beta-lactamase | 0 | 0 | 1 | 4 |
| Metallo-b-lactamase | 0 | 0 | 0 | 5 |
| BlaVIM-1 | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 5 |
| Beta-lactamase class B VIM-2 | 0 | 0 | 1 | 7 |
| Beta-lactamase VIM-1 | 0 | 0 | 0 | 3 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 3 |
| Glutathione peroxidase 1 | 0 | 1 | 0 | 1 |
| Microsomal glutathione S-transferase 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 11 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 1 |
| MecA | 0 | 1 | 0 | 1 |
| TDP1 protein | 7 | 0 | 0 | 7 |
| Smad3 | 1 | 0 | 0 | 1 |
| 67.9K protein | 3 | 0 | 0 | 3 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| Alpha-synuclein | 2 | 0 | 0 | 2 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| Luciferase | 3 | 0 | 0 | 3 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| acetylcholinesterase | 6 | 0 | 0 | 6 |
| PAX8 | 0 | 0 | 0 | 1 |
| glp-1 receptor, partial | 2 | 0 | 0 | 2 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| pregnane X receptor | 2 | 0 | 0 | 2 |
| phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
| RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
| SMAD family member 2 | 2 | 0 | 0 | 2 |
| USP1 protein, partial | 3 | 0 | 0 | 3 |
| SMAD family member 3 | 2 | 0 | 0 | 2 |
| GLI family zinc finger 3 | 5 | 0 | 0 | 5 |
| caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
| PINK1 | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
| estrogen receptor 2 (ER beta) | 5 | 0 | 0 | 5 |
| nuclear receptor subfamily 1, group I, member 3 | 4 | 0 | 0 | 4 |
| progesterone receptor | 5 | 0 | 0 | 5 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 5 | 0 | 0 | 5 |
| glucocorticoid receptor [Homo sapiens] | 6 | 0 | 0 | 6 |
| retinoic acid nuclear receptor alpha variant 1 | 4 | 0 | 0 | 4 |
| retinoid X nuclear receptor alpha | 5 | 0 | 0 | 5 |
| estrogen-related nuclear receptor alpha | 7 | 0 | 0 | 7 |
| farnesoid X nuclear receptor | 3 | 0 | 0 | 3 |
| pregnane X nuclear receptor | 3 | 0 | 0 | 3 |
| G | 6 | 0 | 0 | 6 |
| cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
| glucocerebrosidase | 3 | 0 | 0 | 3 |
| Parkin | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
| peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
| heat shock protein 90 | 0 | 0 | 1 | 1 |
| caspase-3 | 3 | 0 | 0 | 3 |
| IDH1 | 4 | 0 | 0 | 4 |
| euchromatic histone-lysine N-methyltransferase 2 | 6 | 0 | 0 | 6 |
| calcineurin A1, putative | 0 | 0 | 1 | 1 |
| aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| activating transcription factor 6 | 3 | 0 | 0 | 3 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
| Histone H2A.x | 4 | 0 | 0 | 4 |
| cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
| hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
| cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
| cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
| perilipin-5 | 0 | 1 | 0 | 1 |
| thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
| perilipin-1 | 0 | 1 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform 2 | 5 | 0 | 0 | 5 |
| heat shock protein beta-1 | 2 | 0 | 0 | 2 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 0 | 2 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| melanocortin receptor 4 | 0 | 1 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
| CAAX prenyl protease | 0 | 0 | 0 | 1 |
| bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
| geminin | 5 | 0 | 0 | 5 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
| peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
| cytochrome P450 3A4 isoform 1 | 4 | 0 | 0 | 4 |
| glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
| hexokinase HKDC1 | 0 | 1 | 0 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| lamin isoform A-delta10 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit pi | 4 | 1 | 0 | 5 |
| Synaptojanin-2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 3 | 0 | 4 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
| Synaptojanin-1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
| Interferon beta | 7 | 0 | 0 | 7 |
| HLA class I histocompatibility antigen, B alpha chain | 6 | 0 | 0 | 6 |
| Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
| Integrin beta-3 | 2 | 0 | 0 | 2 |
| 72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 2 | 0 | 0 | 2 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 4 | 1 | 0 | 5 |
| Glutamate receptor 2 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 4 | 1 | 0 | 5 |
| Trypanothione reductase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 4 | 1 | 0 | 5 |
| Histamine H2 receptor | 3 | 0 | 0 | 3 |
| Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
| Spike glycoprotein | 7 | 0 | 1 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 4 | 1 | 0 | 5 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| GABA theta subunit | 4 | 1 | 0 | 5 |
| Inositol hexakisphosphate kinase 1 | 6 | 0 | 0 | 6 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
| Ataxin-2 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit epsilon | 4 | 1 | 0 | 5 |
| Spermine oxidase | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 6 | 0 | 0 | 6 |
| thioredoxin reductase | 3 | 0 | 0 | 3 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 6 | 0 | 0 | 6 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
| Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
| Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 4 | 0 | 4 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 6 | 0 | 6 |
| Acetylcholinesterase | 0 | 3 | 0 | 3 |
| Aromatase | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
| Sodium-dependent dopamine transporter | 0 | 3 | 0 | 3 |
| Alpha-1D adrenergic receptor | 0 | 8 | 0 | 8 |
| 5-hydroxytryptamine receptor 2C | 0 | 6 | 1 | 7 |
| Sodium-dependent serotonin transporter | 0 | 4 | 1 | 5 |
| Sodium-dependent serotonin transporter | 0 | 3 | 0 | 3 |
| Histamine H1 receptor | 0 | 4 | 2 | 8 |
| 5-hydroxytryptamine receptor 2B | 0 | 6 | 1 | 7 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 7 | 0 | 7 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 4 | 0 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Transporter | 0 | 4 | 0 | 4 |
| ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 3E | 0 | 1 | 1 | 2 |
| ATAD5 protein, partial | 1 | 0 | 0 | 1 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| GLS protein | 2 | 0 | 0 | 2 |
| Microtubule-associated protein tau | 2 | 0 | 0 | 3 |
| polyprotein | 1 | 0 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
| Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
| Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 1 | 2 |
| Albumin | 0 | 0 | 2 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 6 | 1 | 7 |
| Muscarinic acetylcholine receptor M4 | 0 | 5 | 1 | 6 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 4 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Cytochrome P450 3A4 | 0 | 4 | 0 | 6 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 5 | 0 | 5 |
| Alpha-2A adrenergic receptor | 0 | 8 | 0 | 8 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 4 | 0 | 6 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 5 | 1 | 6 |
| D(2) dopamine receptor | 0 | 6 | 0 | 9 |
| 5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
| Alpha-1B adrenergic receptor | 0 | 6 | 1 | 7 |
| Alpha-2B adrenergic receptor | 0 | 5 | 0 | 5 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 5 | 0 | 5 |
| D | 0 | 3 | 0 | 3 |
| D(3) dopamine receptor | 0 | 3 | 0 | 3 |
| Alpha-2B adrenergic receptor | 0 | 4 | 1 | 5 |
| D(2) dopamine receptor | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M3 | 0 | 5 | 1 | 6 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 4 | 0 | 5 |
| D(4) dopamine receptor | 0 | 2 | 0 | 4 |
| D(1B) dopamine receptor | 0 | 1 | 0 | 2 |
| Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 4 | 1 | 5 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 4 | 1 | 5 |
| Alpha-1D adrenergic receptor | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 4 | 0 | 4 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| D(1B) dopamine receptor | 0 | 3 | 0 | 3 |
| Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 6 | 0 | 8 |
| 5-hydroxytryptamine receptor 1B | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 1D | 0 | 3 | 0 | 3 |
| D(4) dopamine receptor | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 1F | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 2B | 0 | 3 | 1 | 4 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 3 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 6 | 0 | 8 |
| 5-hydroxytryptamine receptor 3A | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 6 | 1 | 7 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 3 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 4 | 0 | 4 |
| Calmodulin | 0 | 0 | 1 | 1 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Transporter | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3D | 0 | 1 | 1 | 2 |
| Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3C | 0 | 1 | 1 | 2 |
| D | 0 | 2 | 0 | 2 |
| Histamine H4 receptor | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 3B | 0 | 3 | 0 | 3 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa] | 1 | 0 | 0 | 1 |
| alpha synuclein, partial | 1 | 0 | 0 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 2 | 0 | 2 |
| 60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Androgen receptor | 0 | 4 | 0 | 4 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, kainate 1 | 1 | 0 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, kainate 2 | 1 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 3 | 1 | 0 | 0 | 1 |
| 10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 1 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, kainate 4 | 1 | 0 | 0 | 1 |
| Leukotriene B4 receptor 1 | 1 | 0 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
| 60 kDa chaperonin | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, kainate 5 | 1 | 0 | 0 | 1 |
| 10 kDa chaperonin | 0 | 2 | 0 | 2 |
| Leukotriene B4 receptor 2 | 1 | 0 | 0 | 1 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Cyclic GMP-AMP synthase | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| Toll-like receptor 9 | 0 | 1 | 0 | 1 |
| Toll-like receptor 7 | 0 | 1 | 0 | 1 |
| CAAX prenyl protease 2 isoform 2 | 0 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| streptokinase A precursor | 0 | 0 | 5 | 5 |
| Tubulin beta-4A chain | 0 | 1 | 0 | 1 |
| Tubulin beta chain | 0 | 1 | 0 | 1 |
| Tubulin alpha-3C chain | 0 | 1 | 0 | 1 |
| Tubulin alpha-1B chain | 0 | 1 | 0 | 1 |
| Tubulin alpha-4A chain | 0 | 1 | 0 | 1 |
| Tubulin beta-4B chain | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| DNA primase | 0 | 1 | 0 | 1 |
| Tubulin beta-3 chain | 0 | 1 | 0 | 1 |
| Tubulin beta-2A chain | 0 | 1 | 0 | 1 |
| Tubulin beta-8 chain | 0 | 1 | 0 | 1 |
| Tubulin alpha-3E chain | 0 | 1 | 0 | 1 |
| Tubulin alpha-1A chain | 0 | 1 | 0 | 1 |
| Tubulin alpha-1C chain | 0 | 1 | 0 | 1 |
| Tubulin beta-6 chain | 0 | 1 | 0 | 1 |
| Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
| Tubulin beta-1 chain | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S6 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S7 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L15 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 2 |
| Estrogen receptor | 0 | 0 | 1 | 1 |
| 50S ribosomal protein L10 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L11 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L7/L12 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L19 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L1 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L20 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L27 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L28 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L29 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L31 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L31 type B | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L32 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L33 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L34 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L35 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L36 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S10 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S11 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S12 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S13 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S16 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S18 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S19 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S20 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S2 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S3 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S4 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S5 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S8 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S9 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L13 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L14 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L16 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L23 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S15 | 0 | 2 | 0 | 2 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L17 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L21 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L30 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L6 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S14 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S17 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S1 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L18 | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L2 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L3 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L24 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L4 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L22 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L5 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S21 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L25 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L36 2 | 0 | 2 | 0 | 2 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 2 | 0 | 3 |
| Beta-lactamase IMP-1 | 0 | 0 | 0 | 2 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 3 | 0 | 5 |
| Histamine H3 receptor | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Glucocorticoid receptor | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Lactoperoxidase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| Beta-lactamase OXA-7 | 0 | 0 | 0 | 1 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| Sialidase | 0 | 1 | 0 | 1 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Sialidase-4 | 0 | 1 | 0 | 1 |
| Sialidase-1 | 0 | 1 | 0 | 1 |
| Sialidase-3 | 0 | 1 | 0 | 1 |
| Sialidase-2 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Beta-lactamase 1 | 0 | 0 | 0 | 1 |
| Beta-lactamase OXA-10 | 0 | 0 | 0 | 1 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Efflux transporter | 0 | 0 | 0 | 1 |
| Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Class D beta-lactamase | 0 | 2 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Beta-lactamase OXA-1 | 0 | 2 | 0 | 3 |
| Metallo-beta-lactamase type 2 | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| B2 bradykinin receptor | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Metallo-beta-lactamase L1 type 3 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
| twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |